[TEVA] QoQ Quarter Result on 30-Jun-2017 [#Q2]

Stock
[TEVA] Teva Pharmaceutical Industries Limited
Announcement Date
11-May-2017
Financial Year
2017
Quarter
30-Jun-2017 [#Q2]
Profit Trend
QoQ- -1,129.31%
YoY- -2,450.39%
Quarter Report
TEVA's Result
TEVA's Financial Summary
View:
Show?
Quarter Result
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
Revenue 5,065,000 5,459,000 5,610,000 5,686,000 5,630,000 6,492,000 5,563,000 -6.06%
PBT 1,254,000 -13,208,000 119,000 -5,978,000 688,000 -914,000 615,000 60.86%
Tax 46,000 -1,471,000 -494,000 -22,000 54,000 57,000 207,000 -63.34%
NP 1,055,000 -11,535,000 530,000 -5,970,000 580,000 -973,000 348,000 109.60%
Tax Rate -3.67% - 415.13% - -7.85% - -33.66% -
Total Cost 4,010,000 16,994,000 5,080,000 11,656,000 5,050,000 7,465,000 5,215,000 -16.08%
Ratio Analysis
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
NP Margin 20.83 -211.30 9.45 -104.99 10.30 -14.99 6.26 123.04%
Per Share
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
EPS 1.04 -11.34 0.52 -5.88 0.57 -0.96 0.35 106.82%
EPS Diluted 1.03 -11.34 0.52 -5.87 0.57 -0.96 0.35 105.49%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.